amplifier bridge amp ml221 Search Results


90
POWERLAB INC data recorder ml866p
Data Recorder Ml866p, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/pressure+transducer+and+amplifier+ml866+and+ml224/pm22835767-57-25-28
Average 90 stars, based on 1 article reviews
data recorder ml866p - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

97
ADInstruments blood pressure amplifiers
Blood Pressure Amplifiers, supplied by ADInstruments, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/Blood+Pressure/10__1080_slash_23312025__2017__1393864-84-23-29
Average 97 stars, based on 1 article reviews
blood pressure amplifiers - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

90
Harvard Bioscience ml221 bridge amplifier
Ml221 Bridge Amplifier, supplied by Harvard Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ml221+bridge+amplifier/10__1161_slash_jaha__119__015222-306-17-10
Average 90 stars, based on 1 article reviews
ml221 bridge amplifier - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
POWERLAB INC ml870
Ml870, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ml870+powerlab+8+30/pmc05635036-454-15-18
Average 90 stars, based on 1 article reviews
ml870 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
MedChemExpress ml221
Ml221, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ML221/custom%40hy-103254%4035355588
Average 94 stars, based on 1 article reviews
ml221 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
TargetMol apelin signaling pathway
FMT from exercised mice activated <t>apelin</t> <t>signaling</t> pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.
Apelin Signaling Pathway, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ML221/pmc11780523-94-1-12
Average 93 stars, based on 1 article reviews
apelin signaling pathway - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
AnaSpec ml221
FMT from exercised mice activated <t>apelin</t> <t>signaling</t> pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.
Ml221, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ml221/pm39497115-72-15-16
Average 90 stars, based on 1 article reviews
ml221 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
POWERLAB INC ml221 amplifier
FMT from exercised mice activated <t>apelin</t> <t>signaling</t> pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.
Ml221 Amplifier, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ml221+amplifier/10__3171_slash_2021__3__spine202056-39-13-17
Average 90 stars, based on 1 article reviews
ml221 amplifier - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Bio-Techne corporation ml 221
FMT from exercised mice activated <t>apelin</t> <t>signaling</t> pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.
Ml 221, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ML+221/custom%404748%4027894959
Average 94 stars, based on 1 article reviews
ml 221 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Novo Nordisk antiserum ml221
FMT from exercised mice activated <t>apelin</t> <t>signaling</t> pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.
Antiserum Ml221, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/antibody+m8309/pm08923846-77-16-18
Average 90 stars, based on 1 article reviews
antiserum ml221 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Selleck Chemicals apelin receptor ml221
a Schematic image of injecting AAVretro-GFP into PVH or ARC, and GFP-labeled cell body sucked by a micropipette. Scale bar, 20 µm. b Volcano plot and bar graph depicting the transcript abundance between PVH-projecting (red) and ARC-projecting (green) apMPOA neurons. c Venn diagram depicting the shared and unique gene expressions of the two neuronal populations. The expression (FPKM) of top ten DEGs in the KEGG pathway categories: metabolism ( d ), environmental information processing ( e ), organismal systems ( f ), cellular processes ( g ). The candidate marker genes are indicated in red #. n = 5 animals for each group. h The genes related to feeding peptides and receptors. The candidate marker genes are indicated in red #. n = 5 animals for each group. i Schematic and representative images of cannula injection of antagonists or agonists of the candidate genes. Scale bar, 100 µm. j Injection of antagonists or agonists of the selected candidate genes during normothermia shows that apelin, galanin, and NPY injections cause food intake changes. One-way repeated-measure ANOVA and post hoc LSD multiple comparison, *** p < 0.001, ** p = 0.01. n = 14 animals. k Feeding test after apelin, galanin and NPY injections. Compared with PBS, apelin-13 robustly suppressed food intake, and the galanin robustly promoted food intake at ambient temperatures. NPY only promoted food intake during normothermia, but not during high or low temperature. Two-way repeated-measure ANOVA and post hoc LSD multiple comparison. Interaction effect: F 6,96 (temperature × drug) = 6.03, *** p < 0.001; main effect: F 2,47 (temperature) = 29.81, *** p < 0.001; F 3,48 (drug) = 28.62, *** p < 0.001. n = 14 animals. l Feeding test after apelin, galanin, and NPY receptors antagonists injections. Compared with PBS, <t>ML221</t> (apelin receptor antagonist) and M40 (GalR1 antagonist) reversed the food intake by the agonists. Blocking the NPY receptor (BIBO 3304) did not induce food intake changes. Two-way repeated-measure ANOVA and post hoc LSD multiple comparison. Interaction effect: F 6,100 (temperature × drug) = 2.4, * p = 0.033; main effect: F 2,49 (temperature) = 29.81, *** p < 0.001; F 3,50 (drug) = 13.43, *** p < 0.001. n = 14 animals. m Colocalizations of GalR1 (green), ARC-projecting apMPOA neurons (red), and fasting-induced C-Fos (purple). Image representative of n = 5 mice. Scale bar, 100 µm. Arrowhead denotes GalR1 +, ARC-projecting+, and C-Fos+ neurons, asterisk denotes GalR1 + and ARC-projecting+ neurons. n ARC-projecting neurons presented colocalization with fasting-induced C-Fos, and galanin receptor 1. o Colocalizations of <t>Aplnr</t> (green), PVH-projecting apMPOA neurons (red), and fasting-induced C-Fos (purple). Image representative of n = 5 mice. Scale bar, 100 µm. Arrowhead denotes Aplnr +, PVH-projecting+, and C-Fos+ neurons, asterisk denotes Aplnr + and PVH-projecting+ neurons. p PVH-projecting neurons presented colocalizations with apelin receptor, but rarely with fasting-induced C-Fos. All error bars show SEM.
Apelin Receptor Ml221, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplifier+bridge+amp+ml221/ML221/pmc09307622-460-80-83
Average 93 stars, based on 1 article reviews
apelin receptor ml221 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


FMT from exercised mice activated apelin signaling pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Theranostics

Article Title: Exercise ameliorates osteopenia in mice via intestinal microbial-mediated bile acid metabolism pathway

doi: 10.7150/thno.104186

Figure Lengend Snippet: FMT from exercised mice activated apelin signaling pathway. (A) PCA plot of samples from TranspCtrl and TranspExer groups (n = 3 per group). (B) Volcano plot of DEGs. (C) Enrichment analysis of upregulated DEGs in the TranspExer group. (D) Heatmap of expression levels of genes associated with the apelin signaling pathway. (E) Relative mRNA expression levels of Apln , Aplnr , Adcy4 , and Adcy5 . (F) Serum apelin concentration. (G) Representative apelin-stained IHC sections. (H) Relative mRNA expression levels of Pparg , Cebpa , Fabp4 , and Lpl . (I) Representative H&E sections depicting adipose tissue. (J-K) Quantitative analysis of J) number of adipocytes and K) adipocytes area. (L) Representative µCT images of tibias in TranspCtrl and TranspExer mice treated with AAV-Ctrl or AAV-Apln. (M-N) Trabecular bone microarchitecture showing BMD and Tb. N. Graphs show mean ± SEM (n = 6 per group), with statistical significance determined by two-tailed student t test in E-F, H, and J-K, and one-way ANOVA followed by Bonferroni's multiple comparisons test in M-N. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: The apelin signaling pathway was suppressed using the apelin receptor antagonist ML221 (TargetMol, USA), wherein mice were administered ML221 (150 μg/kg) via tail vein injections three times a week for 8 weeks .

Techniques: Expressing, Concentration Assay, Staining, Two Tailed Test

a Schematic image of injecting AAVretro-GFP into PVH or ARC, and GFP-labeled cell body sucked by a micropipette. Scale bar, 20 µm. b Volcano plot and bar graph depicting the transcript abundance between PVH-projecting (red) and ARC-projecting (green) apMPOA neurons. c Venn diagram depicting the shared and unique gene expressions of the two neuronal populations. The expression (FPKM) of top ten DEGs in the KEGG pathway categories: metabolism ( d ), environmental information processing ( e ), organismal systems ( f ), cellular processes ( g ). The candidate marker genes are indicated in red #. n = 5 animals for each group. h The genes related to feeding peptides and receptors. The candidate marker genes are indicated in red #. n = 5 animals for each group. i Schematic and representative images of cannula injection of antagonists or agonists of the candidate genes. Scale bar, 100 µm. j Injection of antagonists or agonists of the selected candidate genes during normothermia shows that apelin, galanin, and NPY injections cause food intake changes. One-way repeated-measure ANOVA and post hoc LSD multiple comparison, *** p < 0.001, ** p = 0.01. n = 14 animals. k Feeding test after apelin, galanin and NPY injections. Compared with PBS, apelin-13 robustly suppressed food intake, and the galanin robustly promoted food intake at ambient temperatures. NPY only promoted food intake during normothermia, but not during high or low temperature. Two-way repeated-measure ANOVA and post hoc LSD multiple comparison. Interaction effect: F 6,96 (temperature × drug) = 6.03, *** p < 0.001; main effect: F 2,47 (temperature) = 29.81, *** p < 0.001; F 3,48 (drug) = 28.62, *** p < 0.001. n = 14 animals. l Feeding test after apelin, galanin, and NPY receptors antagonists injections. Compared with PBS, ML221 (apelin receptor antagonist) and M40 (GalR1 antagonist) reversed the food intake by the agonists. Blocking the NPY receptor (BIBO 3304) did not induce food intake changes. Two-way repeated-measure ANOVA and post hoc LSD multiple comparison. Interaction effect: F 6,100 (temperature × drug) = 2.4, * p = 0.033; main effect: F 2,49 (temperature) = 29.81, *** p < 0.001; F 3,50 (drug) = 13.43, *** p < 0.001. n = 14 animals. m Colocalizations of GalR1 (green), ARC-projecting apMPOA neurons (red), and fasting-induced C-Fos (purple). Image representative of n = 5 mice. Scale bar, 100 µm. Arrowhead denotes GalR1 +, ARC-projecting+, and C-Fos+ neurons, asterisk denotes GalR1 + and ARC-projecting+ neurons. n ARC-projecting neurons presented colocalization with fasting-induced C-Fos, and galanin receptor 1. o Colocalizations of Aplnr (green), PVH-projecting apMPOA neurons (red), and fasting-induced C-Fos (purple). Image representative of n = 5 mice. Scale bar, 100 µm. Arrowhead denotes Aplnr +, PVH-projecting+, and C-Fos+ neurons, asterisk denotes Aplnr + and PVH-projecting+ neurons. p PVH-projecting neurons presented colocalizations with apelin receptor, but rarely with fasting-induced C-Fos. All error bars show SEM.

Journal: Nature Communications

Article Title: A temperature-regulated circuit for feeding behavior

doi: 10.1038/s41467-022-31917-w

Figure Lengend Snippet: a Schematic image of injecting AAVretro-GFP into PVH or ARC, and GFP-labeled cell body sucked by a micropipette. Scale bar, 20 µm. b Volcano plot and bar graph depicting the transcript abundance between PVH-projecting (red) and ARC-projecting (green) apMPOA neurons. c Venn diagram depicting the shared and unique gene expressions of the two neuronal populations. The expression (FPKM) of top ten DEGs in the KEGG pathway categories: metabolism ( d ), environmental information processing ( e ), organismal systems ( f ), cellular processes ( g ). The candidate marker genes are indicated in red #. n = 5 animals for each group. h The genes related to feeding peptides and receptors. The candidate marker genes are indicated in red #. n = 5 animals for each group. i Schematic and representative images of cannula injection of antagonists or agonists of the candidate genes. Scale bar, 100 µm. j Injection of antagonists or agonists of the selected candidate genes during normothermia shows that apelin, galanin, and NPY injections cause food intake changes. One-way repeated-measure ANOVA and post hoc LSD multiple comparison, *** p < 0.001, ** p = 0.01. n = 14 animals. k Feeding test after apelin, galanin and NPY injections. Compared with PBS, apelin-13 robustly suppressed food intake, and the galanin robustly promoted food intake at ambient temperatures. NPY only promoted food intake during normothermia, but not during high or low temperature. Two-way repeated-measure ANOVA and post hoc LSD multiple comparison. Interaction effect: F 6,96 (temperature × drug) = 6.03, *** p < 0.001; main effect: F 2,47 (temperature) = 29.81, *** p < 0.001; F 3,48 (drug) = 28.62, *** p < 0.001. n = 14 animals. l Feeding test after apelin, galanin, and NPY receptors antagonists injections. Compared with PBS, ML221 (apelin receptor antagonist) and M40 (GalR1 antagonist) reversed the food intake by the agonists. Blocking the NPY receptor (BIBO 3304) did not induce food intake changes. Two-way repeated-measure ANOVA and post hoc LSD multiple comparison. Interaction effect: F 6,100 (temperature × drug) = 2.4, * p = 0.033; main effect: F 2,49 (temperature) = 29.81, *** p < 0.001; F 3,50 (drug) = 13.43, *** p < 0.001. n = 14 animals. m Colocalizations of GalR1 (green), ARC-projecting apMPOA neurons (red), and fasting-induced C-Fos (purple). Image representative of n = 5 mice. Scale bar, 100 µm. Arrowhead denotes GalR1 +, ARC-projecting+, and C-Fos+ neurons, asterisk denotes GalR1 + and ARC-projecting+ neurons. n ARC-projecting neurons presented colocalization with fasting-induced C-Fos, and galanin receptor 1. o Colocalizations of Aplnr (green), PVH-projecting apMPOA neurons (red), and fasting-induced C-Fos (purple). Image representative of n = 5 mice. Scale bar, 100 µm. Arrowhead denotes Aplnr +, PVH-projecting+, and C-Fos+ neurons, asterisk denotes Aplnr + and PVH-projecting+ neurons. p PVH-projecting neurons presented colocalizations with apelin receptor, but rarely with fasting-induced C-Fos. All error bars show SEM.

Article Snippet: Fifteen min after bilateral injections, the mice were returned to their home cages and feeding behavior tests were performed for 2 h. The drugs were prepared fresh on the day of the experiment by dilution in vehicle solution (PBS supplemented with 0.1% DMSO, 5% PEG400, and 5% Tween-80), including the integrin inhibitor SB273005 (Selleck, 150 nL/unilateral, 1 μM), the enolase inhibitor AP-III-a4 (ENOblock, Selleck, 150 nL/unilateral, 1 μM), the IRAK4 inhibitor PF-06650833 (Selleck, 150 nL/unilateral, 1 μM), the antagonist of apelin receptor ML221 (Selleck, 150 nL/unilateral, 1 μM), the serotonin reuptake inhibitor Fluvoxamine maleate (MK-264, Selleck, 150 nL/unilateral, 1 μM), the antagonist of dopamine D3 receptor BP897 (Adooq Bioscience, 150 nL/unilateral, 1 μM), the antagonist of NPY Y1 receptor BIBO 3304 trifluoroacetate (Tocris, 150 nL/unilateral, 1 μM) and antagonist of galanin receptor M40 (Tocris, 150nL/unilateral, 1 μM).

Techniques: Labeling, Expressing, Marker, Injection, Comparison, Blocking Assay